Biotechnology Stocks I Performance Guide: Rhythm Pharmaceuticals, Inc. (RYTM)
RYTM has no dividends
Table and Chart of RYTM Performance
See what a $1,000 investment in RYTM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RYTM Returns | |
|---|---|
| Start Date | Nov-30-2017 |
| Start Price | $28.58 |
| End Date | Dec-01-2023 |
| End Price | $33.79 |
| # Prices | 74 |
| Min Date | May-31-2022 |
| Min Price | $3.44 |
| Max Date | Dec-01-2023 |
| Max Price | $33.79 |
| Total Return | 18.23% |
| Annualized Return | 2.75% |
| Current Value of $1,000 Purchase | $1,182 |
| Number Returns | 2,701 |
| Average Return | 1.66% |
| Number Profitable Returns | 954 |
| Percent Profitable Returns | 35.32% |
| Number Unprofitable Returns | 1,747 |
| Percent Unprofitable Returns | 64.68% |
| Profitable to Unprofitable Returns Ratio | 0.55 |
| RYTM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,999,827,000 | Price to Sales | 32.26 |
| Earnings per Share | $-3.2400 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 10.1 |
| PRICE DATA | |
| 52 Week High | $35.29 |
| 52 Week Low | $15.5 |
| Analyst Target Price | $40.56 |
| 50-Day Moving Average | $26.34 |
| 200-Day Moving Average | $21.76 |
| FINANCIAL DATA | |
| Revenue per Share | $1.088 |
| Revenue | $61,984,000 |
| Profit Margin | -299.3% |
| Return on Equity | -0.775% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RYTM Compare Returns with S&P 500
RYTM Trendline Chart